DD117250A1 - - Google Patents

Info

Publication number
DD117250A1
DD117250A1 DD18247674A DD18247674A DD117250A1 DD 117250 A1 DD117250 A1 DD 117250A1 DD 18247674 A DD18247674 A DD 18247674A DD 18247674 A DD18247674 A DD 18247674A DD 117250 A1 DD117250 A1 DD 117250A1
Authority
DD
German Democratic Republic
Application number
DD18247674A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DD18247674A priority Critical patent/DD117250A1/xx
Publication of DD117250A1 publication Critical patent/DD117250A1/xx

Links

DD18247674A 1974-11-20 1974-11-20 DD117250A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD18247674A DD117250A1 (https=) 1974-11-20 1974-11-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD18247674A DD117250A1 (https=) 1974-11-20 1974-11-20

Publications (1)

Publication Number Publication Date
DD117250A1 true DD117250A1 (https=) 1976-01-05

Family

ID=5498134

Family Applications (1)

Application Number Title Priority Date Filing Date
DD18247674A DD117250A1 (https=) 1974-11-20 1974-11-20

Country Status (1)

Country Link
DD (1) DD117250A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
US6541001B1 (en) 1999-08-24 2003-04-01 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
US6541001B1 (en) 1999-08-24 2003-04-01 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Similar Documents

Publication Publication Date Title
DK120675A (https=)
FI753121A7 (https=)
DK237475A (https=)
FI751830A7 (https=)
FI751005A7 (https=)
DK24075A (https=)
AU7459074A (https=)
AU7462274A (https=)
FI50465B (https=)
AU6599874A (https=)
BG19680A1 (https=)
DD111875A1 (https=)
BG19872A1 (https=)
BG19828A1 (https=)
BG19825A1 (https=)
BG19772A1 (https=)
BG19768A1 (https=)
BG19764A1 (https=)
BG19878A1 (https=)
AU480170A (https=)
BE829576A (https=)
BG19694A1 (https=)
BG19692A1 (https=)
BG19682A1 (https=)
BE830261A (https=)